Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-14005477Phase 4Recruiting
Phase 4, open-label trial of ephedrine and bupivacaine in supine hypotensive syndrome (SHS) (4 arms), sponsored by The First Affiliated Hospital of Shihezi University. Primary endpoints: Maximum sensory block level, Time to complete block and 10 more. Started Jan 2014; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-14005477.